Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
13.26 EUR | +0.76% | +2.31% | +35.03% |
May. 20 | BTIG Initiates Abivax at Buy Rating With $43 Price Target | MT |
May. 08 | Abivax: four abstracts to be presented on obefazimod | CF |
Official Publications
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- Official Publications